Cannabis leaders

Green Thumb Industries

The company has a very strong position in the rapidly growing Pennsylvania medical cannabis market as well as the Illinois medical cannabis market that will be legal for all adults in January and has a market capitalization of C$2.2 billion. GTI has benefited from wonderful growth in its home state of Illinois throughout much of 2020. It is a multi-state operator with licenses in a dozen states, has rallied 20.5% in 2019 thus far, from its 52-week high it’s down over 40%. Mainly it’s a Chicago-based Green Thumb Industries.

The company has a very strong and establish position in the fast growing Pennsylvania medical cannabis market as well as the Illinois medical cannabis market that will be authorized for all adults in January and has a market capitalization of C$2.2 billion.

Trulieve Cannabis

Trulieve Cannabis concentrates primarily on the Florida medical cannabis market. It rules in the Sunshine State with unevenly 50% of total sales. Trulieve has shined again in 2019 after a good debut in 2018, rising 47.9% year to date and 59.2% since its debut, Down the least from its 52-week high at -22.9%.

The cannabis retailer & grower has been constantly lucrative since 2017. It’s an accomplishment that few other cannabis leading company can claim. Its sales and earnings endure to rise. Trulieve’s next big growing chance is in Massachusetts, they are expecting it to enter the state’s recreational marijuana market in 2021.

Innovative Industrial Properties

The big problem to cannabis is being illegal at the federal level in the U.S. the marijuana companies can’t simply protect capital from financial institution or banks. Anyway, that makes a good big opportunity for (IIP) that buys properties from U.S medical cannabis operators and also leases the properties back to them which provides the cannabis operator the much required cash.

The COVID-19 epidemic upset somewhat IIP’s business though with the renters receiving momentary rent delays due to coronavirus-related financial headwinds. Still, after all these company has still been able to distribute remarkable progress during the epidemic.

Grow Generation

The flourishing U.S. cannabis industry has formed a fast-growing market for supplies for hydroponics (In liquid nutrient plants are growing without soil) and organic garden. Grow Generation has the biggest specialty retail chain focused on this market. Though their business is catering to cannabis growers, they sell to other types of gardeners.

Scotts Miracle-Gro

Scotts Miracle-Gro 

It’s another leading company which benefiting from the same trends that have improved GrowGeneration’s sales. This company’s Hawthorne Gardening subsidiary levels as a leading dealer of hydroponic garden products to the cannabis manufacturing. Though Hawthorne is the major growth driver for Scotts. This company still makes more than 70% of its revenue from sales of its garden products and consumer lawn.

GW Pharmaceuticals

GW Pharmaceuticals’ Epidiolex became the first drug made from a cannabis plant. In 2018 it’s approved by Food and Drug Administration. The cannabis-focused biotech saw new patient starts for Epidiolex little bit slowly with the COVID-19 pandemic, but it continual to transport strong income growth.